Rule 4729:8-3-05 | Corrections to the drug database.
(A) All information required to be submitted in accordance with this division shall be submitted to the drug database in an accurate and timely manner.
(B) If the omission of drug sale information is discovered, the omitted information shall be submitted to the board of pharmacy by the terminal distributor, prescriber, or drug distributor during the next reporting time period after the discovery.
(C) If erroneous drug sale information is discovered, the terminal distributor, drug distributor, or prescriber shall notify the board of pharmacy within twenty-four hours of the discovery. The corrected information must be submitted to the board of pharmacy by the terminal distributor, prescriber, or drug distributor within seven days of the discovery.
(D) If the omission of data or erroneous data is the result of a computer programming error, the terminal distributor, prescriber, or drug distributor must notify the board of pharmacy immediately by telephone and submit written or electronic documentation. The documentation shall fully describe the error and propose a mutually agreed upon date for submitting the corrected information.
(E) Except as noted in paragraph (D) of this rule, all data must be submitted or corrected electronically unless prior permission for an alternate method is granted by the board's executive director or the director's designee.
(F) If utilizing a central fill pharmacy to report to the drug database in accordance with this division of the Administrative Code, the central fill pharmacy and the originating pharmacy shall implement a process to submit a correction if the drug is returned to stock pursuant to rule 4729:5-5-22 of the Administrative Code. It shall be the responsibility of the reporting pharmacy to ensure this process is completed in accordance with this rule.
Last updated August 4, 2025 at 7:47 AM
Supplemental Information